AngioScore

AngioScore Overview

Founded 2003
Founded
Status Acquired/​Merged
Employees 149
Employees
Latest Deal Type M&A
Latest Deal Amount $230M
Latest Deal Amount

AngioScore General Information

Description

Developer of tools for endovascular therapy. The company develops angioplasty catheters for use in the treatment of cardiovascular and vascular disease.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Parent Company
Primary Office
  • 5055 Brandin Court
  • Fremont, CA 94538
  • United States
+1 (510) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AngioScore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 30-Jun-2014 $230M 000.00 00000 Completed Generating Revenue
8. Secondary Transaction - Private 24-Jul-2012 00000 000.00 Completed Generating Revenue
7. Secondary Transaction - Private 000.00 Completed
6. Later Stage VC (Series F) 20-Apr-2011 0000 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series E) 09-Oct-2007 0000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 11-Apr-2006 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 19-Jul-2005 00.000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 23-Aug-2004 $15.1M $16.8M 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 28-Mar-2003 $1.63M $1.63M 00.000 Completed Product Development

AngioScore Cap Table

To view AngioScore‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series D 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series C 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 6,751,590 $0.001000 8% $2.24 $2.24 1x $2.17 15.17%
Series A1 1,632,434 $0.001000 8% $1 $1 1x $1 3.55%

AngioScore Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Intact Vascular Venture Capital-Backed Wayne, PA 00 00000 0000000000 0 00000
00000000 000000000 Venture Capital-Backed Emeryville, CA 00 000.00 00000000000 000.00
0000 000 Formerly PE-Backed Vaulx-en-Velin, France 000 0000 00000000 0000
0000000 Formerly VC-backed Mountain View, CA 00 000.00 000000&0 000.00
000000000 Venture Capital-Backed Tirat Carmel, Israel 000 00000 00000000000 00000

AngioScore Executive Team (11)

Name Title Board Seat Contact Info
Victor Hwang Managing Director
Gary Gershony MD Chief Medical Officer & Founder
Kent Jones Senior Vice President, Regulatory and Quality
Jeff Bleam Vice President, Research & Development
Nancy Chang Advisor

4 Former Executives

AngioScore Board Members (12)

To view AngioScore‘s full board member team, request access »
Name Representing Role Since
James Armstrong Self Board Member 000 0000
Robert Elliott Self Board Member 000 0000

10 Former Board Members

AngioScore Former Investors (10)

To view AngioScore‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Technology Ventures Venture Capital Minority 000 0000 000000 0
Industry Ventures Venture Capital Minority 000 0000 000000 0
Innomed Ventures Venture Capital Minority 000 0000 000000 0
Jerusalem Global Ventures Venture Capital Minority 000 0000 000000 0
Linkagene Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial